{"filing":{"accession_number":"0001104659-26-063936","cik":"0001380106","ticker":null,"company_name":"RAPID MICRO BIOSYSTEMS, INC.","form":"8-K","filing_date":"2026-05-19","report_date":null,"primary_document":"tm2614922d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1380106/000110465926063936/tm2614922d1_8k.htm"},"classifications":[{"id":102,"accession_number":"0001104659-26-063936","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Company entered into an underwriting agreement on May 18, 2026, to conduct an underwritten public offering of 3,581,000 shares of Class A common stock plus pre-funded warrants and multiple series of warrants, with net proceeds of approximately $8.9 million. Additionally, a concurrent registered direct offering to directors and officers for 71,607 shares was executed. These are registered equity issuances that will dilute existing shareholders and raise capital, fitting the dilutive_issuance category. The materiality is clear given the substantial number of shares being issued and the capital raised.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:16:05.431014+00:00","company_name":"RAPID MICRO BIOSYSTEMS, INC.","ticker":null,"filing_date":"2026-05-19"}]}